Notice of Approval of New Animal Drug Application; Ceftiofur

Resumen

The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Pharmacia &Upjohn, Co. The supplemental NADA provided revised susceptibility information for equine pathogens listed in the clinical microbiology section of labeling for ceftiofur sodium sterile powder for injection and added interpretive criteria. The applicable section of the regulations did not require amendment.